Stallimycin

DB20261ExperimentalSmall molecule

Stallimycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Stallimycin is a antibiotic, produced by Streptomyces strain. Stallimycin has a monoisotopic...

Mechanism: Pharmacologically active on High mobility group protein HMG-I/HMG-Y
Curator reviewed
Formula / weight: C₂₂H₂₇N₉O₄ · 481.517 g/mol (avg)
Code names: NSC-82150

Resolves to

Compound

UNII80O63P88ISCAS636-47-5ChEMBLCHEMBL11252

Structure

InChIKeyUPBAOYRENQEPJO-UHFFFAOYSA-NSMILESCN1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC=O)=CN3C)=CN2C)C=C1C(=O)NCCC(N)=N

Targets

P17096HMGA1P04271S100BP17802mutYP17480UBTFP20226TBPP54132BLMQ14191WRN

What you can answer from here — as of August 31, 2026

7Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Stallimycin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account